Catalog No.
Product Name
Application
Product Information
Citations
-
Antibacterial Agent
Tenonitrozole is an antibacterial agent that acts primarily by inhibiting pyruvate-ferredoxin oxidoreductase (PFOR). This compound exhibits notable antibacterial activity against Helicobacter pylori and Campylobacter jejuni, with minimum inhibitory concentrations (MICs) of 0.7 μM and 5.9 μM, respectively. Tenonitrozole is useful in research applications focused on bacterial infections and antibiotic resistance studies. -
Bacterial Inhibitor
Neorauflavene is a phenolic isoflavonoid derived from Neorautanenia edulis, functioning as a bacterial inhibitor. This compound exhibits significant antibacterial activity against various strains, including Enterococcus faecalis, Streptococcus suis, Streptococcus agalactiae, Pseudomonas aeruginosa, Bacillus subtilis, and Riemerella anatipestifer. Neorauflavene's antibacterial properties make it a valuable tool for research in microbiology and the development of therapeutic agents targeting bacterial infections. -
Bacterial Virulence Factor Inhibitor
Anti-virulence factor-IN-1 is a bacterial virulence factor inhibitor that disrupts the bacterial infection process. It demonstrates potent antibacterial activity against Xanthomonas oryzae pv. oryzae (Xoo) with an EC50 value of 0.28 µg/mL. This compound is applicable for the management of rice bacterial leaf blight in vivo and offers significant potential for research related to plant bacterial diseases. -
Antibacterial Agent
Antibacterial Agent 125 is an antibacterial compound that exhibits potent antimicrobial activity against clinically relevant Gram-positive pathogens, with MIC50 values ranging from 0.25 to 8 μM. This compound serves as a valuable tool in research focused on antimicrobial resistance, enabling studies to explore mechanisms of action and resistance patterns in bacterial strains. -
Antibacterial Agent
Antibacterial Agent 75, known as compound 24, functions as a potent antibacterial agent. It has demonstrated efficacy in re-sensitizing vancomycin-resistant Staphylococcus aureus (VRSA) to vancomycin, making it a valuable tool in combating antimicrobial resistance. This compound is essential for research focused on developing strategies to enhance antibiotic effectiveness against resistant bacterial strains. -
Antibacterial Agent
TXY541 is an orally active antibacterial agent that demonstrates potent activity against Staphylococcus aureus. Under physiological conditions, it can be converted to PC190723, which enhances its efficacy. TXY541 exhibits low toxicity to mammalian cells, making it suitable for various antibacterial research applications. -
Bacterial
KSK213 is a 1,2,3-triazole derivative that functions as a potent inhibitor of Chlamydia infectivity, exhibiting a half-maximal effective concentration (EC50) of less than 20 nM. This compound is valuable for research into Chlamydia infections and can aid in the development of therapeutic strategies against bacterial pathogens. Its high potency makes it an essential tool for studying bacterial infectivity mechanisms and evaluating potential antimicrobial treatments. -
Bacterial Peptide Deformylase Inhibitor
Lanopepden camsylate is a high-affinity inhibitor of bacterial peptide deformylase, an enzyme critical for protein maturation in bacteria. This compound exhibits potent activity against bacterial infections by disrupting essential protein processing. Lanopepden camsylate is primarily utilized in research applications focused on the development of new antibacterial agents and the study of bacterial pathogenicity. -
Bacterial Inhibitor
TP-271 is a bacterial inhibitor specifically designed to target pathogens associated with community-acquired pneumonia. This compound exhibits significant antimicrobial activity, making it suitable for research applications focused on bacterial infections and respiratory diseases. Its potential to disrupt bacterial growth presents promising avenues for further exploration in the development of effective therapeutics. -
Bacterial Inhibitor
Cefonicid is a broad-spectrum beta-lactam antibiotic targeting bacterial cell wall synthesis. It exhibits potent antibacterial activity against a variety of Gram-positive and Gram-negative bacteria, making it valuable in treating various infectious diseases. Pharmacokinetic studies indicate that high plasma concentrations are swiftly attained following intravenous or intramuscular administration, and its half-life may be extended with concomitant use of albendazole, leading to reduced renal clearance. Cefonicid serves as an essential tool in bacterial infection research and the development of therapeutic strategies. -
Anti-bacterial Agent
3′-Omethyl-5′-hydroxydiplacone is a C-6-geranylflavonoid with demonstrated antibacterial activity, specifically targeting Gram-positive bacteria. This compound, isolated from the ethanol extract of Paulownia tomentosa fruits, serves as a valuable tool for studies focused on bacterial inhibition and antimicrobial research. Its unique structure and functionality make it of interest for investigating the mechanisms of antibacterial agents. -
Antibacterial Agent
Antibacterial Agent 116 is a benzophenone-containing salicylanilide compound that acts by inhibiting peptidoglycan formation, a critical component of bacterial cell walls. This compound demonstrates potent antibacterial activity and serves as a photoaffinity probe to specifically label Acinetobacter baumannii penicillin-binding protein (PBP1b). Its use is vital in research applications focused on understanding bacterial growth mechanisms and developing strategies to combat antibiotic resistance. -
β-lactamase Inhibitor
β-Lactamase-IN-4 is a potent β-lactamase inhibitor that targets β-lactamase enzymes, effectively enhancing the efficacy of β-lactam antibiotics. This compound is critical for research applications focused on combating bacterial infections caused by β-lactamase-producing microorganisms. Its use may contribute to the development of novel therapeutic strategies against resistant bacterial strains. -
Bacterial Inhibitor
Penicillin N is a penicillin-type antibiotic that primarily targets bacterial cell wall synthesis. It exhibits potent antibacterial activity against enteric bacilli, making it effective for the treatment of infections caused by these pathogens. This compound is widely utilized in microbiological research to study antibacterial mechanisms and evaluate susceptibility of bacterial strains. -
Bacterial Inhibitor
Methyl sterculate is a potent bacterial inhibitor that targets Δ9 desaturase. This compound effectively inhibits the growth of Rhodococcus opacus at a concentration of 0.75 mM, demonstrating toxicity towards the bacteria. Furthermore, it alters the fatty acid profile by decreasing overall fatty acid content while increasing the palmitate ratio and reducing stearate and oleate levels at concentrations of 0.25 or 0.5 mM. Methyl sterculate also exhibits a synergistic effect on tumor growth induced by aflatoxin Q1 in rainbow trout at a concentration of 50 ppm. -
Antibacterial Agent
Cis-2-Dodecenoic acid is an antibacterial agent that disrupts bacterial quorum sensing mechanisms. Derived from Burkholderia cenocepacia, this compound effectively inhibits biofilm formation and the production of virulence factors in bacteria. Its unique action makes it valuable for research into antimicrobial resistance and biofilm-related infections. -
Bacterial Inhibitor
Quorum sensing-IN-2 is a potent quorum sensing inhibitor that targets bacterial communication mechanisms to diminish pathogenicity while preserving overall bacterial growth. This compound effectively reduces bacterial infections with minimal hemolytic activity. Additionally, Quorum sensing-IN-2 exhibits a synergistic effect when combined with Ciprofloxacin in models of Pseudomonas aeruginosa PAO1 bacteremia, making it a valuable tool for investigating bacterial virulence and developing novel therapeutic strategies. -
Quinone Antibiotic
Granaticinic acid is a quinone antibiotic derived from Streptomyces thermoviolaceus NT1. It exhibits significant anti-gram-positive bacterial activity, making it a valuable compound for researching bacterial infections. Its unique mechanism of action provides insights into antibiotic resistance and the development of new therapeutic agents. -
Antibacterial Agent
Pachyaximine A is an alkaloid derived from the root of Sarcococca hookeriana, primarily recognized for its antibacterial properties. This compound exhibits significant activity against bacterial strains, making it a valuable tool for research focused on combating bacterial infections. Its unique mechanism of action and natural origin position Pachyaximine A as an important candidate in the development of novel antibacterial agents. -
Antibacterial Agent
Antibacterial Agent 77 primarily targets bacterial cell growth. This compound exhibits significant antibacterial activity, making it suitable for research applications aimed at investigating bacterial infections and developing new antimicrobial therapies. Its effectiveness against various bacterial strains can provide insights into mechanisms of resistance and the potential for therapeutic interventions. -
Antibacterial/Anticancer Agent
AJI-9561 is a benzoxazole derivative that functions as an antibacterial and anticancer agent. This compound demonstrates significant cytotoxic effects, inhibiting the proliferation of Jurkat T cells and mouse P388 leukemia cells, with IC50 values of 0.88 µM and 1.63 µM, respectively. AJI-9561 is suitable for research focused on exploring its potential therapeutic applications in oncology and infectious diseases. -
Microbial Metabolite
Benanomicin A is a microbial metabolite derived from Actinomycetes, known for its antifungal properties. It demonstrates significant inhibitory effects on HIV-1 viral infection in MT-4 cells. This compound is useful in research applications targeting fungal infections and viral replication mechanisms. -
Antibacterial Agent
Sperabillin A is an antibacterial agent that exhibits activity against both gram-positive and gram-negative bacteria. In addition to its antibacterial properties, Sperabillin A demonstrates significant inhibition of human umbilical vein endothelial (HUVE) cell proliferation. Notably, it also displays anti-tumor activity against B16 melanoma in mouse models, making it a valuable compound for studying bacterial infections as well as cancer biology. -
Anti-bacterial Agent
(-)-Decursinol is a natural pyranocoumarin compound derived from the roots of Apiaceae plants, such as Ferulago campestris. This compound exhibits potent antibacterial activity, effectively inhibiting both Gram-positive bacteria, including Staphylococcus aureus and Enterococcus faecalis, and Gram-negative bacteria such as Salmonella typhii and Enterobacter species, with minimum inhibitory concentrations ranging from 16 to 64 μg/mL. Additionally, (-)-Decursinol demonstrates antioxidant properties, making it valuable for research applications focused on bacterial infections and oxidative stress. -
Anti-bacterial Agent
Almurtide (nor-MDP) is a muramyl dipeptide derivative functioning as an anti-bacterial agent. It exhibits significant anti-inflammatory and anti-tumor properties, alongside protective effects against infections caused by Pseudomonas aeruginosa and Candida albicans in murine models. Additionally, Almurtide demonstrates inhibitory effects on the carcinogenic Friend leukemia virus, making it relevant for cancer research and infectious disease studies. -
Bacterial
N-Heptanoyl-L-homoserine lactone is an N-acyl-homoserine lactone that targets the quorum sensing mechanisms of gram-negative bacteria. This compound is involved in the regulation of gene expression, facilitating communication between bacterial cells. It is primarily utilized in research applications focused on bacterial pathogenesis and biofilm formation, providing insights into microbial behavior and interactions. -
Antibacterial Peptide
Hc-CATH is an antibacterial peptide derived from sea snake cathelicidin, exhibiting broad-spectrum antimicrobial activity. It effectively inhibits the growth of Shigella dysenteriae and Klebsiella pneumoniae, with minimum inhibitory concentrations (MIC) ranging from 0.16 mM to 20.67 mM. Additionally, Hc-CATH demonstrates anti-inflammatory properties, making it a valuable tool for research in the fields of infectious disease and inflammation. -
Antibacterial Agent
CP-74667 is a quinolone antibacterial agent with potent activity against various bacterial strains. It exhibits significant inhibitory effects on Xanthomonas maltophilia with a MIC50 of 1 μg/mL, as well as Staphylococcus spp. (MIC50 = 0.06-0.12 μg/mL) and enterococci (MIC50 = 0.5-4 μg/mL). This compound is valuable for research applications targeting bacterial infections and assessing antibiotic efficacy. -
Bacterial Inhibitor
ORM-3819 is a bacterial inhibitor targeting Staphylococcus aureus. This compound exhibits broad-spectrum antimicrobial activity against both methicillin-susceptible (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). Additionally, ORM-3819 reduces the phagocytosis of MRSA and MSSA strains by monocytic THP-1 cells, making it valuable for research related to bacterial infections and resistance mechanisms. Its efficacy in combatting staphylococcal infections positions it as a critical tool in antimicrobial studies. -
Anti-Bacterial Agent
Roseorubicin B is an anti-bacterial agent with notable activity against Gram-positive bacteria and Mycobacterium species. Additionally, it exhibits inhibitory effects on leukemia L1210 cells, with an IC50 value of 0.06 μg/mL. This compound is valuable for research applications focusing on bacterial infections and cancer therapeutics. -
Bacterial Inhibitor
4-Glycidyloxycarbazole is an antimicrobial agent that targets bacterial biofilm formation. It exhibits significant inhibitory activity against various bacterial strains, making it a valuable tool for studying bacterial behavior and infection control. This compound is useful in research applications focused on biofilm-related challenges in microbiology and infectious disease. -
Antibacterial Agent
Delmopinol is an antibacterial agent that targets oral bacteria to inhibit the formation of dental biofilm. Its primary mechanism involves interference with microbial adhesion and biofilm development, making it a valuable reagent for research focused on oral health and hygiene. This compound is especially useful in studies investigating the prevention of dental plaque and associated diseases. -
Antibacterial Agent
Antibacterial Agent 194 is a potent antibacterial compound targeting Mycobacterium tuberculosis (Mtb). It exhibits significant antimicrobial activity with a minimum inhibitory concentration (MIC) of 1 μg/mL. This agent is valuable for research applications focused on combating tuberculosis and understanding the mechanisms of bacterial resistance. -
Antibacterial Agent
SCUT1-2 is a bifunctional antibacterial agent targeting Clostridium difficile. It demonstrates significant antibacterial activity, effectively killing vegetative cells with a minimum inhibitory concentration (MIC) of 0.06-0.50 μg/mL, while also inhibiting spore germination in vitro. In preclinical models, SCUT1-2 has shown efficacy in alleviating symptoms associated with C. difficile infection, including weight loss and diarrhea, and in preventing recurrent infections. -
CcrM Inhibitor
NSC177365 is a potent CcrM inhibitor that acts by competitively disrupting DNA binding. It demonstrates significant antibacterial activity, displaying IC50 values of 2.3 μM and 14.6 μM against C. crescentus and M. lincolnii, respectively. Furthermore, NSC177365 has potential applications in reversing neurodegenerative disorders and shows promise as an anticancer agent, making it a valuable tool for chemical research. -
Antibacterial agent
Anti-MRSA agent 16 is an inhibitor of methicillin-resistant Staphylococcus aureus (MRSA). This compound demonstrates potent antibacterial activity and shows enhanced efficacy when used in combination with oxacillin or meropenem in in vivo models, specifically in infected mice. It is a valuable tool for researchers investigating treatments for MRSA infections. -
Antibacterial Agent
BMY-28271 is an orally active cephalosporin that functions as a potent antibacterial agent. It exhibits a broad spectrum of activity against both gram-positive and gram-negative bacteria, making it a valuable compound for combating bacterial infections. Additionally, BMY-28271 demonstrates resistance to hydrolysis by various beta-lactamases, enhancing its efficacy in research applications focused on infection treatment and antibiotic resistance mechanisms. -
Bacterial Inhibitor
KSK120 is a potent bacterial inhibitor targeting Chlamydia trachomatis (C. trachomatis). It disrupts the developmental cycle of the bacteria, leading to a reduction in the infectivity of progeny by targeting the glucose-6-phosphate metabolic pathway. KSK120 is particularly relevant for research into antimicrobial strategies, as its mechanism may involve inhibition of transcriptional processes, offering a novel approach for the development of targeted therapies against C. trachomatis infections. -
Antibacterial Agent
c[Arg-Arg-Arg-Arg-Dip-Dip-Dip] is an antibacterial agent that demonstrates broad-spectrum activity against both drug-resistant Gram-positive and Gram-negative bacteria. It exhibits minimum inhibitory concentrations (MICs) of 3.1 μg/mL against MRSA (ATCC BAA-1556) and S. aureus (ATCC 29213), along with 12.5 μg/mL for P. aeruginosa (ATCC 27883) and E. coli (ATCC 25922). This compound is valuable for research applications focused on combating antibiotic resistance in pathogenic bacteria. -
Bacterial Inhibitor
10-Isobutyryloxy-8,9-epoxythymol isobutyrate is a bacterial inhibitor derived from Inula helenium and Inula royleana root cultures, exhibiting moderate antimicrobial activity. This compound demonstrates efficacy against various pathogens, including Staphylococcus aureus, Enterococcus faecalis, Candida albicans, and Pseudomonas aeruginosa, with MIC values of 50, 250, 250, 250, and 1000 μg/mL, respectively. It serves as a valuable tool for research in antibacterial studies and the exploration of potential therapeutic agents. -
VIM-Type Metallo-β-lactamase Inhibitor
Metallo-β-lactamase-IN-6 is a potent inhibitor of VIM-type metallo-β-lactamases, demonstrating IC50 values of 0.56 μM for VIM-2, 29.50 μM for VIM-1, and 5.78 μM for VIM-5. This compound exhibits significant antibacterial synergy with Meropenem against engineered Escherichia coli strains and clinically isolated Pseudomonas aeruginosa strains that produce VIM-2 metallo-β-lactamase. It serves as a valuable research tool for exploring resistance mechanisms in bacterial pathogens and for developing novel therapeutic strategies. -
Bacterial Inhibitor
LolCDE-IN-3 is an inhibitor targeting the LolCDE complex, which plays a critical role in bacterial lipid A transport. This compound exhibits potent antibacterial activity, making it a valuable tool for studying bacterial physiology and pathogen resistance mechanisms. It is suitable for research applications focused on antibiotic development and the exploration of novel antibacterial strategies. -
Bacterial Inhibitor
OV-1, sheep is an alpha-helical antimicrobial peptide derived from the SMAP29 peptide of sheep, specifically designed to target and inhibit a range of antibiotic-resistant bacterial strains. This compound demonstrates significant efficacy against both mucoid and nonmucoid strains of Pseudomonas aeruginosa. OV-1, sheep is a valuable tool for research applications focusing on antimicrobial resistance and the development of peptide-based therapeutics. -
Bacterial Inhibitor
GSK729 is a selective inhibitor of EchA6, a critical enzyme involved in the fatty acid biosynthesis pathway of Mycobacterium tuberculosis. By specifically targeting and inhibiting EchA6, GSK729 demonstrates significant bactericidal activity, effectively obstructing the growth of the bacterium. This compound is valuable for research applications focused on the development of new therapeutic strategies against tuberculosis and exploring the role of fatty acid synthesis in bacterial pathogenesis. -
β-lactamase Inhibitor
FPI-1602 is a β-lactamase inhibitor that enhances the efficacy of β-lactam antibiotics. It exhibits significant antimicrobial activity against pathogens such as Pseudomonas aeruginosa, Escherichia coli, and Enterobacter spp. This compound is valuable for research applications aimed at overcoming antibiotic resistance mediated by β-lactamase enzymes. -
Antibacterial/Antiparasitic Agent
Levofuraltadone is an antibacterial and antiparasitic agent primarily targeting Trypanosoma parasites. It exhibits significant anti-trypanosomiasis activity, making it a valuable tool in the study of human African trypanosomiasis. Additionally, Levofuraltadone can be utilized in researching various bacterial infections, contributing to the understanding of microbial pathogenesis and treatment strategies. -
Antibacterial Agent
Viscosin is a cyclic lipopeptide with potent antibacterial properties, targeting bacterial membranes and cell wall synthesis. It demonstrates significant efficacy against a range of Gram-positive bacteria, making it a valuable tool for investigating bacterial infections. Notably, Viscosin exhibits no antifungal activity. This compound serves as an essential reagent for research focused on bacterial pathogenesis and antimicrobial drug development. -
Antibacterial Agent
L-K6L9 is an antibacterial agent exhibiting notable antimicrobial and antibiofilm activities against Pseudomonas aeruginosa, particularly in isolates from cystic fibrosis patients. This compound demonstrates stability and resilience against degradation by sputum proteases commonly found in cystic fibrosis, while also minimizing the risk of inducing bacterial resistance. It serves as a valuable tool for research focused on developing novel therapeutic strategies for bacterial infections in cystic fibrosis. -
Antibacterial Activity
Moracin T is a natural compound isolated from the bark of mulberry trees, known for its antibacterial properties. It exhibits significant activity against a range of bacterial strains, making it a valuable candidate for research in antibiotic development and microbial resistance studies. Its efficacy in inhibiting bacterial growth positions Moracin T as a pertinent tool for investigating potential therapeutic applications in infectious diseases. -
Parasite Inhibitor
Melilotigenin C is a natural product derived from the genus Erythrina, primarily acting as a parasite inhibitor. It exhibits significant antiplasmodial activity, making it a candidate for studies focused on malaria treatment. Additionally, Melilotigenin C demonstrates antimycobacterial properties and presents potential for cytotoxicity research, contributing to the exploration of new therapeutic agents against infectious diseases.
